Core Viewpoint - Society Pass Incorporated has announced a public offering of 1,500,000 shares at a price of $2.00 per share, aiming for gross proceeds of $3 million, expected to close on December 31, 2025 [1] Group 1: Offering Details - The public offering consists of 1,500,000 shares priced at $2.00 each, targeting gross proceeds of $3 million before expenses [1] - Rodman & Renshaw LLC is the exclusive placement agent for this offering [2] - The offering is conducted under a registration statement declared effective by the SEC on December 29, 2025 [3] Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital and general corporate purposes, including operating expenses and capital expenditures [2] Group 3: Company Overview - Society Pass was founded in 2018 and operates in Southeast Asia, focusing on e-commerce across Vietnam, Indonesia, Philippines, Singapore, and Thailand, which represent over 80% of the SEA population [5] - The company operates in three interconnected verticals: digital media, travel, and lifestyle, leveraging technology to enhance customer experience [5] - Society Pass went public in November 2021 and trades on Nasdaq under the ticker SOPA [6]

MONTRÉAL, Dec. 19, 2025 /PRNewswire/ -- Vision Marine Technologies Inc. (the "Company", "Vision Marine", "we", "us", "our") (Nasdaq: VMAR), a leader in high-voltage electric marine propulsion systems with a multi-brand boat retail and service platform, today announced the closing of its previously announced best- efforts public offering of 32,000,000 units at a public offering price of $0.30 per unit (inclusive of the pre- funded warrant exercise price), for gross proceeds of $9,600,000 before deducting pla ...

LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...

LONDON, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering (the “Offering”) of 1,739,130 common shares, together with accompanying warrants to purchase 869,565 common sha ...

BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying common stock warrants to purchase an aggrega ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce the pricing and terms of its previously announced public offering. The ...

Core Viewpoint - Biodexa Pharmaceuticals PLC has announced a public offering priced at $10 million, aimed at funding its development programs and general corporate purposes [2][3]. Offering Details - The offering consists of 157,000 ADS Units, each comprising one American depositary share (representing 100,000 ordinary shares) and two Series L warrants [2]. - Additionally, there are 2,891,781 Pre-Funded Units, each consisting of one pre-funded warrant to purchase one ADS and two Series L Warrants [2]. - The public offering price for each ADS Unit is set at $3.28, while each Pre-Funded Unit is priced at $3.2799 [2]. Financial Proceeds - The expected gross proceeds from the offering, before deducting fees and expenses, are approximately $10 million [3]. - The net proceeds will be utilized for development programs, working capital, and other corporate purposes [3]. Closing and Agent Information - The offering is anticipated to close on December 19, 2025, pending customary closing conditions [4]. - Maxim Group LLC is acting as the sole placement agent for this offering [4]. Company Overview - Biodexa Pharmaceuticals PLC is a clinical stage biopharmaceutical company focused on developing innovative treatments for diseases with unmet medical needs [7]. - The company's lead programs include eRapa for Familial Adenomatous Polyposis and Non-Muscle Invasive Bladder Cancer, tolimidone for type 1 diabetes, and MTX110 for aggressive rare/orphan brain cancer [7]. Product Details - eRapa is an oral formulation of rapamycin, an mTOR inhibitor involved in cellular metabolism and tumorigenesis [8]. - Tolimidone is a selective inhibitor of Lyn kinase, showing potential for glycaemic control in diabetes [9]. - MTX110 is a formulation of panobinostat designed for direct delivery to tumors, bypassing the blood-brain barrier [10][11].

Core Viewpoint - Vision Marine Technologies Inc. announced a public offering of 32,000,000 units at a price of $0.30 per unit, aiming to raise gross proceeds of $9,600,000 before expenses [1][2]. Group 1: Offering Details - Each unit consists of one common share (or a Pre-Funded Warrant) and one-half of one Warrant, with each whole Warrant allowing the purchase of one common share at an exercise price of $0.375 [1]. - The offering is expected to close on December 19, 2025, pending customary closing conditions [1]. - The common shares and Warrants will be issued separately, but must be purchased together in even numbers [1]. Group 2: Use of Proceeds - The proceeds from the offering will primarily be used for general corporate purposes, including inventory management, servicing floorplan lines of credit, general and administrative expenses, and prosecuting patent applications for the E-Motion™ electric powertrain technology [2]. Group 3: Company Overview - Vision Marine Technologies is a leader in high-voltage electric marine propulsion systems and operates a multi-brand boat retail and service platform [1][4]. - The company offers an integrated ecosystem that spans propulsion, retail, service, and on-water consumer engagement through its E-Motion™ propulsion platform and Nautical Ventures retail network [4].

Core Viewpoint - Actelis Networks, Inc. has announced a public offering of 6,250,000 shares of common stock at a price of $0.80 per share, aiming to raise approximately $5 million in gross proceeds for general corporate purposes [1][2]. Group 1: Offering Details - The public offering includes warrants to purchase an additional 6,250,000 shares of common stock, with an exercise price of $0.80 per share, exercisable upon issuance and expiring five years thereafter [1]. - The closing of the offering is expected around December 19, 2025, pending customary closing conditions [1]. Group 2: Financial Information - The gross proceeds from the offering are anticipated to be $5 million before deducting placement agent fees and other expenses [2]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering [2]. Group 3: Company Overview - Actelis Networks, Inc. specializes in hybrid fiber and cyber-hardened networking solutions for IoT applications across various sectors, including government, military, and telecom [5]. - The company’s offerings provide fiber-grade performance while maintaining the flexibility and cost-efficiency of hybrid fiber-copper networks [5]. - Actelis also emphasizes network security through its "Cyber Aware Networking" initiative, which includes AI-based cyber monitoring and protection for edge devices [5].

Core Viewpoint - Lightwave Logic, Inc. is proposing to offer and sell its common stock in an underwritten public offering, aiming to leverage its proprietary electro-optic polymers for data transmission at higher speeds and lower power consumption [1] Company Summary - The company specializes in technology platforms that utilize proprietary electro-optic (EO) polymers [1] - The public offering will include a 30-day option for underwriters to purchase up to an additional 15% of the common stock to cover over-allotments [1]